Drugs / abnobaVISCUM Fraxini
last change Apr 2015 re-read 3 minutes ago

abnobaVISCUM Fraxini

Developed for
superficial urinary bladder carcinoma
Investigated by
Abnoba GmbH

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02007005 Jan 2004 → Feb 2012 superficial urinary bladder carcinoma Abnoba GmbH Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as abnobaVISCUM Fraxini ClinicalTrials.gov intervention name — accepted as the source's own label NCT02007005 ↗
Route Other “intravesical instillation of mistletoe extract” PMID 25910967 ↗ Apr 2015